IMVARIA is advancing noninvasive AI biomarkers for better patient lives. We bring artificial intelligence to imaging and lab data, re-imagining clinical assessments in serious diseases. IMVARIA serves Fibresolve -- the first AI diagnostic tool in interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF). Fibresolve is an FDA Breakthrough Device and is authorized by the FDA to serve as an adjunctive, non-invasive diagnostic tool for patients with suspected ILD and IPF. Beyond ILD and IPF, IMVARIA is developing AI biomarkers in multiple areas including oncology, pulmonology, immunology, and more.



Berkeley, CA, USA

IMVARIA

Meridian Street Capital is a investment fund seeking to partner with Midwest companies looking to grow and scale their businesses. The firm seeks to invest in established companies looking for expansion as well as early stage entrepreneurs seeking funds and guidance. The firm is based in Indianapolis, Indiana.

Meridian Street Capital, LLC

Meridian Street Capital

Join one of our fast growing companies engineering the future of healthcare

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Meridian Street Capital Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Meridian Street Capital network as they come up.

You can always update this information later.

Welcome to the Meridian Street Capital talent network

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Meridian Street Capital company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Open Opportunities